ArticleMedical oncology (Northwood, London, England)2026
Disparities and burden of illness among hospitalized cancer patients with opioid dependence.
Article in Medical oncology (Northwood, London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Opoid dependency (OD) is associated with adverse clinical outcomes in hospitalized patients; nevertheless, the understanding of OD and its impact on cancer patients remains restricted. Alongside addressing the symptoms related to disease, hospitalized patients with OD also grapple with mental illness (MI) challenges and the risk of infectious consequences (ICs), which remain unrecognized in cancer patients. We utilized national inpatient database to examine patient and clinical characteristics among renal cell carcinomas (RCC), prostate cancers (PC) and cancers of the lip, oral cavity, and pharynx (CLOP). We used generalized linear models to evaluate the association of OD and outcome of burden of illness (BOI), specifically length of stay (LOS). We also evaluated the association between OD and emergency department (ED) referral/admission status, ICs (specifically septicemias), weight loss, fluid and electrolyte disorders (FED), status of MI screening, and anxiety and depressive disorders. Of the 88,105 RCC there were 610 OD patients; PC (209,410) with 1115 OD; CLOP (54,265) with 495 OD. PC patients with OD were associated with longer LOS (Coefficient, 1.59; 95%CI, 1.14-2.21), higher ED status (aOR, 2.60; 1.47-4.59), higher FED (aOR, 2.25;1.59-3.19), higher septicemia (aOR, 1.61;1.09-2.39), less MI screening (aOR: 0.59, 95%CI, 0.40-0.89), higher anxiety disorders (aOR,2.31;1.53-3.48), and higher depressive disorders (aOR, 2.22; 1.48-3.33). Similarly, RCC OD patients were associated with ED status (1.66; 1.01-2.73), FED (2.40;1.50-3.83) and septicemias (2.61;1.27-2.39). These findings were comparable in the CLOP cohorts. Among all cancer cohorts, compared to Whites, Hispanics were associated with more septicemias, and Blacks, when compared to Whites, had a longer LOS. The findings are particularly significant in light of the ongoing opioid epidemic and its effects on cancer patients. In exceptional clinical situations, including a high risk of mental disorder, exact criteria must be created for controlling cancer pain that allow safe opioid delivery, taking into account biological and psychosocial OD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.